The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Structural Heart Disease Interventional Device Market Research Report 2025

Global Structural Heart Disease Interventional Device Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1902240

No of Pages : 87

Synopsis
The global Structural Heart Disease Interventional Device market was valued at US$ 85400 million in 2023 and is anticipated to reach US$ 268070 million by 2030, witnessing a CAGR of 18.3% during the forecast period 2024-2030.
North American market for Structural Heart Disease Interventional Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Structural Heart Disease Interventional Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Structural Heart Disease Interventional Device include Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic, Terumo, B. Braun, Lepu Medical, Koninklijke Philips NV and Biosensors International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Structural Heart Disease Interventional Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Structural Heart Disease Interventional Device.
Report Scope
The Structural Heart Disease Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Structural Heart Disease Interventional Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Structural Heart Disease Interventional Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Boston Scientific
Edwards Lifesciences
Medtronic
Terumo
B. Braun
Lepu Medical
Koninklijke Philips NV
Biosensors International
Meril Life Sciences
Segment by Type
Percutaneous Interventional Devices
Thoracotomy Instruments
Segment by Application
Congenital Heart Disease
Valvular Disease
Cardiomyopathy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Structural Heart Disease Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Structural Heart Disease Interventional Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Structural Heart Disease Interventional Device Market Overview
1.1 Product Overview and Scope of Structural Heart Disease Interventional Device
1.2 Structural Heart Disease Interventional Device Segment by Type
1.2.1 Global Structural Heart Disease Interventional Device Market Value Comparison by Type (2024-2030)
1.2.2 Percutaneous Interventional Devices
1.2.3 Thoracotomy Instruments
1.3 Structural Heart Disease Interventional Device Segment by Application
1.3.1 Global Structural Heart Disease Interventional Device Market Value by Application: (2024-2030)
1.3.2 Congenital Heart Disease
1.3.3 Valvular Disease
1.3.4 Cardiomyopathy
1.3.5 Others
1.4 Global Structural Heart Disease Interventional Device Market Size Estimates and Forecasts
1.4.1 Global Structural Heart Disease Interventional Device Revenue 2019-2030
1.4.2 Global Structural Heart Disease Interventional Device Sales 2019-2030
1.4.3 Global Structural Heart Disease Interventional Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Structural Heart Disease Interventional Device Market Competition by Manufacturers
2.1 Global Structural Heart Disease Interventional Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Structural Heart Disease Interventional Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Structural Heart Disease Interventional Device Average Price by Manufacturers (2019-2024)
2.4 Global Structural Heart Disease Interventional Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Structural Heart Disease Interventional Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Structural Heart Disease Interventional Device, Product Type & Application
2.7 Structural Heart Disease Interventional Device Market Competitive Situation and Trends
2.7.1 Structural Heart Disease Interventional Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Structural Heart Disease Interventional Device Players Market Share by Revenue
2.7.3 Global Structural Heart Disease Interventional Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Structural Heart Disease Interventional Device Retrospective Market Scenario by Region
3.1 Global Structural Heart Disease Interventional Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Structural Heart Disease Interventional Device Global Structural Heart Disease Interventional Device Sales by Region: 2019-2030
3.2.1 Global Structural Heart Disease Interventional Device Sales by Region: 2019-2024
3.2.2 Global Structural Heart Disease Interventional Device Sales by Region: 2025-2030
3.3 Global Structural Heart Disease Interventional Device Global Structural Heart Disease Interventional Device Revenue by Region: 2019-2030
3.3.1 Global Structural Heart Disease Interventional Device Revenue by Region: 2019-2024
3.3.2 Global Structural Heart Disease Interventional Device Revenue by Region: 2025-2030
3.4 North America Structural Heart Disease Interventional Device Market Facts & Figures by Country
3.4.1 North America Structural Heart Disease Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Structural Heart Disease Interventional Device Sales by Country (2019-2030)
3.4.3 North America Structural Heart Disease Interventional Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Structural Heart Disease Interventional Device Market Facts & Figures by Country
3.5.1 Europe Structural Heart Disease Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Structural Heart Disease Interventional Device Sales by Country (2019-2030)
3.5.3 Europe Structural Heart Disease Interventional Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Structural Heart Disease Interventional Device Market Facts & Figures by Country
3.6.1 Asia Pacific Structural Heart Disease Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Structural Heart Disease Interventional Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Structural Heart Disease Interventional Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Structural Heart Disease Interventional Device Market Facts & Figures by Country
3.7.1 Latin America Structural Heart Disease Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Structural Heart Disease Interventional Device Sales by Country (2019-2030)
3.7.3 Latin America Structural Heart Disease Interventional Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Structural Heart Disease Interventional Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Structural Heart Disease Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Structural Heart Disease Interventional Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Structural Heart Disease Interventional Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Structural Heart Disease Interventional Device Sales by Type (2019-2030)
4.1.1 Global Structural Heart Disease Interventional Device Sales by Type (2019-2024)
4.1.2 Global Structural Heart Disease Interventional Device Sales by Type (2025-2030)
4.1.3 Global Structural Heart Disease Interventional Device Sales Market Share by Type (2019-2030)
4.2 Global Structural Heart Disease Interventional Device Revenue by Type (2019-2030)
4.2.1 Global Structural Heart Disease Interventional Device Revenue by Type (2019-2024)
4.2.2 Global Structural Heart Disease Interventional Device Revenue by Type (2025-2030)
4.2.3 Global Structural Heart Disease Interventional Device Revenue Market Share by Type (2019-2030)
4.3 Global Structural Heart Disease Interventional Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Structural Heart Disease Interventional Device Sales by Application (2019-2030)
5.1.1 Global Structural Heart Disease Interventional Device Sales by Application (2019-2024)
5.1.2 Global Structural Heart Disease Interventional Device Sales by Application (2025-2030)
5.1.3 Global Structural Heart Disease Interventional Device Sales Market Share by Application (2019-2030)
5.2 Global Structural Heart Disease Interventional Device Revenue by Application (2019-2030)
5.2.1 Global Structural Heart Disease Interventional Device Revenue by Application (2019-2024)
5.2.2 Global Structural Heart Disease Interventional Device Revenue by Application (2025-2030)
5.2.3 Global Structural Heart Disease Interventional Device Revenue Market Share by Application (2019-2030)
5.3 Global Structural Heart Disease Interventional Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Structural Heart Disease Interventional Device Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Structural Heart Disease Interventional Device Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Edwards Lifesciences
6.3.1 Edwards Lifesciences Corporation Information
6.3.2 Edwards Lifesciences Description and Business Overview
6.3.3 Edwards Lifesciences Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Edwards Lifesciences Structural Heart Disease Interventional Device Product Portfolio
6.3.5 Edwards Lifesciences Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medtronic Structural Heart Disease Interventional Device Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Corporation Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Terumo Structural Heart Disease Interventional Device Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Corporation Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 B. Braun Structural Heart Disease Interventional Device Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 Lepu Medical
6.6.1 Lepu Medical Corporation Information
6.6.2 Lepu Medical Description and Business Overview
6.6.3 Lepu Medical Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lepu Medical Structural Heart Disease Interventional Device Product Portfolio
6.7.5 Lepu Medical Recent Developments/Updates
6.8 Koninklijke Philips NV
6.8.1 Koninklijke Philips NV Corporation Information
6.8.2 Koninklijke Philips NV Description and Business Overview
6.8.3 Koninklijke Philips NV Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Koninklijke Philips NV Structural Heart Disease Interventional Device Product Portfolio
6.8.5 Koninklijke Philips NV Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Corporation Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biosensors International Structural Heart Disease Interventional Device Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 Meril Life Sciences
6.10.1 Meril Life Sciences Corporation Information
6.10.2 Meril Life Sciences Description and Business Overview
6.10.3 Meril Life Sciences Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Meril Life Sciences Structural Heart Disease Interventional Device Product Portfolio
6.10.5 Meril Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Structural Heart Disease Interventional Device Industry Chain Analysis
7.2 Structural Heart Disease Interventional Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Structural Heart Disease Interventional Device Production Mode & Process
7.4 Structural Heart Disease Interventional Device Sales and Marketing
7.4.1 Structural Heart Disease Interventional Device Sales Channels
7.4.2 Structural Heart Disease Interventional Device Distributors
7.5 Structural Heart Disease Interventional Device Customers
8 Structural Heart Disease Interventional Device Market Dynamics
8.1 Structural Heart Disease Interventional Device Industry Trends
8.2 Structural Heart Disease Interventional Device Market Drivers
8.3 Structural Heart Disease Interventional Device Market Challenges
8.4 Structural Heart Disease Interventional Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’